# Janus Henderson Biotech Innovation Fund Ltd — Form D

Janus Henderson Biotech Innovation Fund Ltd of GRAND CAYMAN, E9, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2026-06-09. $441.2M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2026-06-09
- Form: D
- Accession: 0002131527-26-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b,3C,3C.7
- Amount sold: $441.2M
- Minimum investment: $100K
- Investors: 81
- Security types: fund interests
- SEC file number: 021-586706

## Issuer

- Name: Janus Henderson Biotech Innovation Fund Ltd
- CIK: 0002131527
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Address: C/O MAPLES CORPORATE SERVICES LTD BOX 309, UGLAND HOUSE, GRAND CAYMAN, E9, KY1-1104
- Phone: 345-949-8066

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Matteo Candolfini | Related Person | Grand Cayman, E9 |
| Toby Hiscock | Related Person | Grand Cayman, E9 |
| Kenneth Lubbock | Related Person | Grand Cayman, E9 |
| Hugh Ward | Related Person | Grand Cayman, E9 |

## More

- [CIK 2131527 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2131527&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002131527-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.